---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-25-000101"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2025-08-15T23:59:59+00:00"
generated_at: "2026-05-17T12:25:14.055147+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Salarius Pharmaceuticals effects 1-for-15 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse split effective 5:00 p.m. ET on August 15, 2025; trading on split-adjusted basis from August 18, 2025.
- Shares outstanding reduced from ~7.6M to ~509,000; no fractional shares, cash in lieu paid.
- New CUSIP number 79400X503; authorized shares and par value unchanged.
- Split approved by stockholders at July 8, 2025 special meeting; ratio set by Board.

## SEC filing metadata
- accession: 0001615219-25-000101
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2025-08-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000101/0001615219-25-000101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000101/flks-20250815.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-25-000101
- JSON: https://secwatch.observer/filing/0001615219-25-000101.json
- Plain text: https://secwatch.observer/filing/0001615219-25-000101.txt

## Key facts
- Governance Changes
  Decoy Therapeutics Inc.: Filed a Certificate of Amendment to effect a 1-for-15 reverse stock split of common stock (effective 2025-08-15).
  - Change: charter amendment
  - Effective: 2025-08-15
  source text: On August 15, 2025, Salarius Pharmaceuticals, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s amended and restated certificate of incorporation (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware , to effect a 1-for-15 reverse stock split (the “reverse split”) of the Company’s issued and outstanding shares of common stock, par value $0.0001 per share (the “ Common Stock ”), effective at 5:00 p.m. Eastern Time on that date (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000101/0001615219-25-000101-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.